|
|
Post by afrezzamiracle on Aug 12, 2014 0:47:52 GMT -5
|
|
|
|
Post by jpg on Aug 12, 2014 2:27:18 GMT -5
I wonder if Mr. Kliff understands that he is betting his reputation and standing on these Mannkind bashes? He is basicaly saying Sanofi is clueless. I have read the guy for a while and now think of him as one of those 'grumpy old past due date' advisors. If he is wrong he basically makes his opinion irrellavent to any paying subscriber to his diabetic feed. He (and AF to a lesser degree) could easily become the poster child's for clueless diabetes/ biotech investor advisors.
If we Mannkind longs are right who would ever pay for advice from the 'diabetic market specialists' who missed the biggest pure play diabetic drug company in the last 20-30 years? Mr. Kliff and AF have been wrong at every step if the process so far. Why do they think they will now, so late in the game, turn out to be right? At least they are predictable... Makes you wonder if they are convinced bears or 'convincible' bears...
JPG
|
|
|
|
Post by notamnkdmillionaire on Aug 12, 2014 6:51:30 GMT -5
Isn't Kliff the same guy who has been wrong about Afrezza at every stage and has always shown hostility towards the company? Here's what AF quoted Kliff as writing back in 10/14/13 "The real news is that today's announcement really isn't news at all and in fact does nothing to change the future outlook for the company. Let's assume for a moment that everything actually goes well for the company and that Afrezza is approved by the FDA and that by some miracle the company actually does find a partner. What happens then? Not much if you look at the market realistically. Yes it is true there will be some early adaptors who will use Afrezza but Diabetic Investor suspects the reception for Afrezza will be somewhat muted." www.thestreet.com/story/12068260/1/diabetic-investors-kliff-on-mannkind-boringly-predictable.htmlWell Mr. Kliff, not only have you been wrong 100% so far, but Big Miracles actually do happen. Who knew Santa worked for Sanofi?  |
|
|
|
Post by Chris-C on Aug 12, 2014 9:05:17 GMT -5
Isn't Kliff the same guy who has been wrong about Afrezza at every stage and has always shown hostility towards the company? Here's what AF quoted Kliff as writing back in 10/14/13 "The real news is that today's announcement really isn't news at all and in fact does nothing to change the future outlook for the company. Let's assume for a moment that everything actually goes well for the company and that Afrezza is approved by the FDA and that by some miracle the company actually does find a partner. What happens then? Not much if you look at the market realistically. Yes it is true there will be some early adaptors who will use Afrezza but Diabetic Investor suspects the reception for Afrezza will be somewhat muted." www.thestreet.com/story/12068260/1/diabetic-investors-kliff-on-mannkind-boringly-predictable.htmlWell Mr. Kliff, not only have you been wrong 100% so far, but Big Miracles actually do happen. Who knew Santa worked for Sanofi? Frankly, the longer I am an investor, the more astonished I am that the industry continues to flourish in the face of rampant incompetence and corruption. David Kliff is an entrepreneur "registered investment advisor" who is also a diabetic. But the fact that he has an investment blog that specializes in reviewing diabetic investment opportunities does not make him an expert in either area. He has no formal medical or scientific training and he specializes in opinions. That he has been consistently wrong about Mannkind validates an essential truth about "analysts" and people in general. Once we make up our minds about a particular conclusion, we blind ourselves to information that is dissonant with that conclusion because to admit error opens up the possibilities that some of our other conclusions may also be flawed. We all feel vulnerable in those moments. Thus, it is likely that nothing is going to change Mr. Kliff's mind. When the sales start adding up, he may continue to deny, perhaps ultimately "capitulating" by saying that he was always correct but that adopters and patients have been misled by marketing. Unfortunately, Mr. Kliff's blog has exposure and there are millions of naive people who assume that because he has a blog he is an expert. It is always wise to get multiple opinions and to determine the credibility of a source. Kliff can blog with impunity because he is giving opinions. (That protects much of the misinformation that is abundant on the web and poses as informed investment advice.) But for my money, I will place more credibility in Matthew Pfeffer. Of the two, he is in a far better position to know what he is talking about. And although some may argue that a Mannkind executive will have a bias or conflict of interest, I will offer that the difference is that a representative of the company has a legal obligation to avoid distorting facts, not to mention his moral accountability to shareholders and patients. An entrepreneur, investment advisor will be motivated principally to attract readers to his website. In the end, the blog and Kliff's opinion will minimal or no influence sales of the drug or Sanofi's success in marketing it. GLTAL Chris-C |
|
|
|
Post by ezrasfund on Aug 12, 2014 9:59:36 GMT -5
As an example there is a guy I followed for a while around 2008 because he called the housing bust and the banking crash with excellent timing, Reggie Middleton's Boombust Blog. He has been telling people to short AAPL for years now because "margin compression is inevitable." Every time AAPL spikes and then sells off he congratulates himself on how smart he is.
|
|
